ASCO 2026: Latest updates in mRCC
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of September 14 - 19.
Dr Morgan covers papers from The Journal of Clinical Oncology, The New England Journal of Medicine, Annals of Oncology, Clinical Cancer Research, European Journal of Urology, Cancer, The Lancet Oncology,
He also highlights some early news from ESMO 2020, the ASCO Advocacy Summit and FDA approval news.
You can watch Dr Morgan's previous roundup for September 6-13 2020 here.
Follow Dr Morgan on twitter.
Follow ecancer on twitter.
ASCO 2026: Latest updates in mRCC
ASCO GU 2026: Updates in metastatic prostate cancer
Key insights from lung cancer research at ASCO 2025
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Neo-adjuvant therapy for different cancers in the Philippines